Prevalence of Hypertension in Ghana: Analysis of an Awareness and Screening Campaign in 2019.
Ashanti region
Ghana
Hypertension
May Measurement Month
blood pressure
Journal
Clinical Medicine Insights. Cardiology
ISSN: 1179-5468
Titre abrégé: Clin Med Insights Cardiol
Pays: United States
ID NLM: 101525768
Informations de publication
Date de publication:
2022
2022
Historique:
received:
25
10
2021
accepted:
28
07
2022
entrez:
5
9
2022
pubmed:
6
9
2022
medline:
6
9
2022
Statut:
epublish
Résumé
Hypertension is an important public health menace globally and in sub-Saharan Africa. The prevalence of hypertension is on the rise in low- and lower-middle-income countries (LMIC) such as Ghana. This rise led to the adoption of the May Measurement Month (MMM) initiative, a global blood pressure screening campaign. We aimed to create awareness and present the findings of the 2019 MMM screening campaign in the Ashanti region of Ghana. Ghana was 1 of 92 countries that participated in this global community-based cross-sectional study in May 2019. Participants (⩾18 years) were recruited by opportunistic sampling. The blood pressures of participants were measured 3 times and the mean of the last 2 was used for the analysis. Summary statistics were used to describe the data. Simple and multiple logistic regression models were used to determine the predictors of hypertension. We screened 3080 participants with a mean age of 39.8 ± 16.8 years. The prevalence of hypertension was 27.3% among participants. Two-thirds of the hypertensives were unaware of their condition and only 49.5% of participants with a history of hypertension on medication were controlled. Predictors of hypertension in a multiple logistic regression were increasing age (OR = 1.05 (CI 1.04-1.06), The MMM initiative is highly commendable and of huge public health importance in LMICs like Ghana. Population-based health programs such as the MMM initiative is encouraged to shape appropriate public health policies to reduce the prevalence of hypertension.
Identifiants
pubmed: 36060113
doi: 10.1177/11795468221120092
pii: 10.1177_11795468221120092
pmc: PMC9434666
doi:
Types de publication
Journal Article
Langues
eng
Pagination
11795468221120092Informations de copyright
© The Author(s) 2022.
Déclaration de conflit d'intérêts
Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
Hypertension. 2020 Aug;76(2):333-341
pubmed: 32419505
Lancet. 2005 Jan 15-21;365(9455):217-23
pubmed: 15652604
PLoS One. 2019 Apr 5;14(4):e0214934
pubmed: 30951534
Arch Intern Med. 2002 May 13;162(9):1051-8
pubmed: 11996617
PLoS One. 2014 Aug 04;9(8):e104300
pubmed: 25090232
Eur Heart J. 2019 Jul 1;40(25):2006-2017
pubmed: 31041440
BMC Public Health. 2010 Jul 14;10:418
pubmed: 20626917
Eur Heart J Suppl. 2021 May 20;23(Suppl B):B62-B65
pubmed: 34248431
Postgrad Med. 2010 Mar;122(2):35-48
pubmed: 20203454
J Am Soc Hypertens. 2015 Mar;9(3):235-7; quiz 238
pubmed: 25670252
J Clin Hypertens (Greenwich). 2013 Oct;15(10):742-7
pubmed: 24088283
Lancet. 2008 May 3;371(9623):1513-8
pubmed: 18456100
Eur Heart J Suppl. 2020 Aug;22(Suppl H):H59-H61
pubmed: 32884472
PLoS One. 2018 Nov 7;13(11):e0205985
pubmed: 30403686
Int J Environ Res Public Health. 2019 Nov 26;16(23):
pubmed: 31779087
Korean J Fam Med. 2018 Nov;39(6):325-332
pubmed: 30384549
Clin Cardiol. 2017 Oct;40(10):783-788
pubmed: 28692760
Int J Hypertens. 2019 Oct 07;2019:1089578
pubmed: 31687204
PLoS One. 2021 Apr 1;16(4):e0248934
pubmed: 33793641
BMC Cardiovasc Disord. 2020 Mar 11;20(1):123
pubmed: 32156259
BMC Public Health. 2016 Dec 9;16(1):1239
pubmed: 27938360
Curr Pharm Des. 2006;12(13):1581-92
pubmed: 16729871
JAMA. 2013 Sep 4;310(9):959-68
pubmed: 24002282